Company Name: |
ShangHai Biochempartner Co.,Ltd
|
Tel: |
17754423994 17754423994 |
Email: |
2853530910@QQ.com |
Products Intro: |
Product Name:SGK1-IN-4 CAS:1628048-93-0 Purity:98% HPLC LCMS Package:100mg;500mg;1g
|
Company Name: |
Shanghai Chaolan Chemical Technology Center
|
Tel: |
QQ:65489617 15618227136 |
Email: |
info@SuperLan-chem.com |
Products Intro: |
Product Name:SGK1-IN-4 CAS:1628048-93-0 Purity:98% Package:5MG;10MG;50MG;100MG,1G,5G,100G
|
|
| Benzenesulfonamide, 5-chloro-2-fluoro-N-[4-[4-[(trans-4-hydroxycyclohexyl)oxy]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]- Basic information |
Product Name: | Benzenesulfonamide, 5-chloro-2-fluoro-N-[4-[4-[(trans-4-hydroxycyclohexyl)oxy]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]- | Synonyms: | Benzenesulfonamide, 5-chloro-2-fluoro-N-[4-[4-[(trans-4-hydroxycyclohexyl)oxy]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-;SGK1-IN-4 (compound 17a);SGK1-IN-4;Serum and glucocorticoid-regulated kinase,SGK,Serum-glucocorticoid regulated kinase,SGK1 IN 4,osteoarthritis,Inhibitor,orally active,SGK1 inhibitor,SGK1IN4,inhibit | CAS: | 1628048-93-0 | MF: | C23H21ClFN5O4S | MW: | 517.96 | EINECS: | | Product Categories: | | Mol File: | 1628048-93-0.mol | ![Benzenesulfonamide, 5-chloro-2-fluoro-N-[4-[4-[(trans-4-hydroxycyclohexyl)oxy]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]- Structure](CAS/20210305/GIF/1628048-93-0.gif) |
| Benzenesulfonamide, 5-chloro-2-fluoro-N-[4-[4-[(trans-4-hydroxycyclohexyl)oxy]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]- Chemical Properties |
density | 1.543±0.06 g/cm3(Predicted) | solubility | DMSO : 250 mg/mL (482.66 mM; Need ultrasonic) | form | Solid | pka | 5.76±0.10(Predicted) | color | Off-white to light yellow |
| Benzenesulfonamide, 5-chloro-2-fluoro-N-[4-[4-[(trans-4-hydroxycyclohexyl)oxy]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]- Usage And Synthesis |
Biological Activity | SGK1-IN-4 (compound 17a) is a highly selective, orally active SGK1 inhibitor. SGK1-IN-4 can be used for osteoarthritis research[1]. | References | [1]. Nis Halland, et al. Rational Design of Highly Potent, Selective, and Bioavailable SGK1 Protein Kinase Inhibitors for the Treatment of Osteoarthritis. J Med Chem. 2022 Jan 27;65(2):1567-1584. |
| Benzenesulfonamide, 5-chloro-2-fluoro-N-[4-[4-[(trans-4-hydroxycyclohexyl)oxy]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]- Preparation Products And Raw materials |
|